Evidence map›Paper›PMID 41166356›Full record

ArticlePloS one2025

Weakly-supervised explainable infection severity classification from chest CT scans.

Ibrahim Almakky, Mohammad Yaqub

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ibrahim AlmakkyMohamed Bin Zayed University of Artificial Intelligence, Abu Dhabi, United Arab Emirates.ORCID https://orcid.org/0009-0008-8802-7107
Mohammad YaqubMohamed Bin Zayed University of Artificial Intelligence, Abu Dhabi, United Arab Emirates.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Novel respiratory diseases can have a devastating impact on healthcare systems, which underlines the importance of developing methods to improve the prevention, diagnosis, and prognosis of such diseases. Developing computer-aided diagnosis tools that determine infection severity can aid healthcare professionals in deciding treatment strategies and preventing cross-infection. In such manner, lung infection severity classification from chest CTs is crucial for deciding treatment plans and interventions needed to block illness progression in individual patients and reduce cross infection. However, current techniques face performance, generalizability, and explainability challenges for automated infection severity classification methods due to the high spatial complexity of 3D volumes. Significant efforts have been focused on segmentation approaches to quantify lung infection and assess infection severity, but such segmentation methods require expensive data annotation and clinical expertise. In this work, we propose a weakly-supervised classification approach to distinguish between different levels of infection, while providing clinicians with explainable results. To mimic clinical practice, the different stages in our approach focus on low-level infection patterns as well as high-level infection coverage in lung CT scans. We then fuse the high-level features with the positionally encoded low-level features to provide volume-level infection classification. Testing on the SARS-CoV-2 (COVID-19) multi-centre multi-region datasets, our approach shows promising performance gains compared to existing state-of-the-art methods, where we achieve state-of-the-art severity classification performance. Furthermore, we show significant performance gains on cross-site train/test splits. Finally, we quantitatively and qualitatively demonstrate the explainability of our weakly-supervised approach, where we can achieve substantial infection coverage.

Indexed as

COVID-19LungTomography, X-Ray ComputedAlgorithmsHumansSARS-CoV-2Severity of Illness Index

Identifiers

PMID41166356
PMCPMC12574926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.